What are ACAD share price targets?

Their ACAD share price targets range from $19.00 to $42.00. On average, they expect the company's stock price to reach $28.94 in the next twelve months. This suggests a possible upside of 94.3% from the stock's current price. View analysts price targets for ACAD or view top-rated stocks among Wall Street analysts.

Where can I buy ACAD stock?

Shares of ACAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here.

Is Acad A real company?

Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA. ACAD Stock Soared to a Four-Month High.